Results 161 to 170 of about 19,218 (261)

Locally Advanced Basal Cell Carcinoma With Orbital Invasion: Treatment With Neoadjuvant Hedgehog Pathway Inhibition and Palliative Enucleation. [PDF]

Cureus
Murphy MA.
europepmc   +1 more source

c‐Met‐Targeted Imaging Agents: Progress and Challenges

iRADIOLOGY, EarlyView.
This review summarizes recent advances in c‐Met‐targeted imaging probes, including hepatocyte growth factor (HGF) ligands, antibodies, peptides, and small molecules across magnetic resonance imaging (MRI), positron emission tomography (PET), single‐photon emission computed tomography (SPECT), and optical imaging modalities.
Yonghao Li, Aiyan Ji, Qihang Ding, Hongyue Lou, Zhen Cheng   +4 more
wiley   +1 more source

Clinical Outcomes of Sonidegib in Vismodegib-Exposed Locally Advanced Basal Cell Carcinoma: Insights From a Multicenter Descriptive Study. [PDF]

J Skin Cancer
Prados-Carmona A, Martínez-Pérez M, Velasco-Amador JP, Almazán-Fernández FM, Ruiz-Villaverde R.   +4 more
europepmc   +1 more source

A Case of a Locally Advanced Periorbital Basal Cell Carcinoma

Journal of Ophthalmic Studies, 2018
McVeigh K, Vahdani K, Garrott H, Ford R
openaire   +1 more source

Beyond Tradition: An Integrated Toxicological, Ecological, and Public Health Perspective on Aristolochic Acids

Journal of Applied Toxicology, EarlyView.
ABSTRACT Aristolochia species have long been used in traditional medicine for their presumed anti‐inflammatory, analgesic and antimicrobial properties. However, extensive toxicological and epidemiological evidence now demonstrates that these plants contain aristolochic acids (AAs) I and II, highly potent nephrotoxic, genotoxic, and carcinogenic ...
Victor Ventura de Souza, Lara Rodrigues De Andrade, Tatiana da Silva Souza   +2 more
wiley   +1 more source

Prognostic Value of Combined FDG PET and MRI Analysis of Cervical Cancer: A Systematic Review and Meta‐Analysis

Journal of Medical Radiation Sciences, EarlyView.
This systematic review and meta‐analysis synthesised FDG PET/MRWE biomarkers in cervical cancer, including a pooled analysis of the association between metabolic activity (SUV‐based metrics) and tumour diffusion characteristics (ADC measures). Prognostic evidence from the included studies was also analysed to identify PET‐ and MRI‐based parameters, as ...
William Wei, Dominic Ku, Natalie Rutherford   +2 more
wiley   +1 more source

Pathological Insights into the Limitations of Clinical and Dermoscopic Evaluations in Monitoring Sonidegib Treatment Response for Locally Advanced Basal Cell Carcinoma: A Real-World Study. [PDF]

Dermatol Ther (Heidelb)
Liu X, Zhan J, Zou J, Chen R, Zhong J, He R.   +5 more
europepmc   +1 more source

Emerging trends in the treatment of advanced basal cell carcinoma

, 2018
Basal cell carcinoma (BCC) is the most commonly diagnosed skin cancer worldwide. In most patients, BCC can be effectively treated with standard surgical excision, Mohs micrographic surgery, curettage and electrodessication, radiotherapy, and/or ...
Migden, M.R., Stratigos, A.J., Chang, A.L.S., Dirix, L., Lear, J.T.   +4 more
core  

Supplementary Material for: Management of Locally Advanced Basal Cell Carcinoma with Sonic Hedgehog Pathway Targeted Therapy: A Case Report and Discussion

Introduction Basal Cell Carcinoma (BCC) is the most common skin malignancy in the world. While most lesions are treated using surgical methods, others may present as locally advanced or metastatic disease and are not amenable to surgical therapy alone ...
Jones R. (17956232), Ferrin N. (17956226), Edmond D. (17956229), McCahill L.E. (17956235)   +3 more
core   +1 more source

Optimising hypoxia PET imaging and its applications in guiding targeted radiation therapy for non‐small cell lung cancer: a scoping review

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 106-118, March 2025.
This review article reports that quantification of hypoxic volumes using PET in the pre‐radiation therapy setting is of prognostic value and indicative of treatment response in non‐small cell lung cancer. Abstract Introduction Non‐small cell lung cancer (NSCLC) is the leading cause of cancer‐related death. Definitive treatment includes chemotherapy and
Carol Marks, Michelle Leech
wiley   +1 more source